Did you know that in an emergency you could be enrolled in a clinical trial without your consent? How is this possible and what can you do about it?
Ask yourself this: How often do you think about your ability to hear? Or this: How much would you, or your loved ones, be affected if your hearing was diminished, or lost completely? Not a pretty picture, so learn here how to best protect this incredible gift.
In Part 1 we discussed the RO1 grant, the bread and butter of academic research funding. Here, in Part 2, we delve into what happens to a grant after it is submitted – and how select grants are awarded funding.
Scientific research is not cheap. But what is the process that academic scientists go through in order to receive funding for their work? This article – the first of a two-part series – describes this stressful and highly competitive procedure.
The prevalence of dementia in the United States significantly declined from 11.6 percent in 2000 to 8.8 percent in 2012. The consequence of this impacts retirement, families, the health care system, life expectancy, morbidity and mortality, pensions, housing, transportation and countless societal realms.
Almost as if this was a sci-fi movie, virtually every time that new information about Zika surfaces it's bad. This trend continued this week as the CDC's Dr. Anne Schuchat, and Dr. Anthony Fauci of the NIH held a mostly-discouraging press briefing at the White House.
A new report finds that few entities administering clinical trials governmental agencies, nonprofits and academic institutions and private companies are reporting data to the government, as is required. The most common reason given for failure to do so on time (or at all) was that it's too much work.
CDC Follies, part two. No, part three. Well, whatever: our nation s chief repository of biological threats (i.e. bioterror weapons, potentially) resembles the gang that couldn t shoot straight. They keep spreading lethal organisms around.
A recent study shows that early treatment for HIV results in a significant decrease in early illness and death. "It's just more scientific evidence to back what we've been saying for a time now," said Dr. Anthony Fauci, director of the National Institute for Allergy and Infectious Diseases, part of the National Institutes of Health which funded the
We at ACSH are fortunate to have amongst our erudite Advisors Dr. David Shlaes, one of the world experts in the fields of both antibiotic research and FDA regulatory policies. Shlaes has been intimately involved with the FDA, which he has both criticized and worked with, trying to prevent us from entering a pre-penicillin age, when there were no effective treatments for bacterial infections.
What is complementary-alternative medicine anyway? Alternative to what? If a practice is not science-based, it is not medicine. Now we learn that Cleveland Clinic has sold out this concept for herbal treatments. Sad.
In the world of drug research, the language can be a little unusual. For example, it is fair to say that easier disease targets, such as HIV, hepatitis C, ulcers and high blood pressure, and certain cancers, have seen advances that have resulted in game changing therapies for those diseases.